The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance Melanoma
Clinical trial NCT00626860 · COMPLETED
Trial details
- NCT number
- NCT00626860
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-07-01
- Primary completion
- 2002-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.